NO161743C - Fremgangsm. for fremst. av krystallinsk natriumsalt av 7-(d(-(-)-a-(4-etyl-2,3-diokso-1-piperazinkarboksamido)-a-(4-hydroksyfenyl)acetamido)-3-(((1-metyl-1h-tetrazol-5-yl)tio)metyl)-3-cefem-4-karboksylsyre (cefoperazon). - Google Patents

Fremgangsm. for fremst. av krystallinsk natriumsalt av 7-(d(-(-)-a-(4-etyl-2,3-diokso-1-piperazinkarboksamido)-a-(4-hydroksyfenyl)acetamido)-3-(((1-metyl-1h-tetrazol-5-yl)tio)metyl)-3-cefem-4-karboksylsyre (cefoperazon).

Info

Publication number
NO161743C
NO161743C NO832598A NO832598A NO161743C NO 161743 C NO161743 C NO 161743C NO 832598 A NO832598 A NO 832598A NO 832598 A NO832598 A NO 832598A NO 161743 C NO161743 C NO 161743C
Authority
NO
Norway
Prior art keywords
methyl
cefoperazon
crystallic
cefem
tetrazol
Prior art date
Application number
NO832598A
Other languages
English (en)
Norwegian (no)
Other versions
NO832598L (no
NO161743B (no
Inventor
Susumu Nakanishi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO832598L publication Critical patent/NO832598L/no
Publication of NO161743B publication Critical patent/NO161743B/no
Publication of NO161743C publication Critical patent/NO161743C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
NO832598A 1982-07-19 1983-07-18 Fremgangsm. for fremst. av krystallinsk natriumsalt av 7-(d(-(-)-a-(4-etyl-2,3-diokso-1-piperazinkarboksamido)-a-(4-hydroksyfenyl)acetamido)-3-(((1-metyl-1h-tetrazol-5-yl)tio)metyl)-3-cefem-4-karboksylsyre (cefoperazon). NO161743C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/399,400 US4458070A (en) 1982-07-19 1982-07-19 Process for the manufacture of crystalline sodium cefoperazone

Publications (3)

Publication Number Publication Date
NO832598L NO832598L (no) 1984-01-20
NO161743B NO161743B (no) 1989-06-12
NO161743C true NO161743C (no) 1989-09-20

Family

ID=23579363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832598A NO161743C (no) 1982-07-19 1983-07-18 Fremgangsm. for fremst. av krystallinsk natriumsalt av 7-(d(-(-)-a-(4-etyl-2,3-diokso-1-piperazinkarboksamido)-a-(4-hydroksyfenyl)acetamido)-3-(((1-metyl-1h-tetrazol-5-yl)tio)metyl)-3-cefem-4-karboksylsyre (cefoperazon).

Country Status (29)

Country Link
US (1) US4458070A (sv)
EP (1) EP0101170B1 (sv)
JP (1) JPS5929692A (sv)
KR (1) KR860001495B1 (sv)
AU (1) AU537776B2 (sv)
CA (1) CA1190219A (sv)
CS (1) CS235331B2 (sv)
DD (1) DD213219A5 (sv)
DE (1) DE3361849D1 (sv)
DK (1) DK152051C (sv)
EG (1) EG16058A (sv)
ES (1) ES8501372A1 (sv)
FI (1) FI75169C (sv)
GR (1) GR79593B (sv)
GT (1) GT198302734A (sv)
HK (1) HK99487A (sv)
HU (1) HU192961B (sv)
IE (1) IE55433B1 (sv)
IL (1) IL69261A (sv)
MY (1) MY8700729A (sv)
NO (1) NO161743C (sv)
NZ (1) NZ204930A (sv)
PH (1) PH19441A (sv)
PL (1) PL145167B1 (sv)
PT (1) PT77041B (sv)
SG (1) SG69787G (sv)
SU (1) SU1194281A3 (sv)
YU (1) YU44123B (sv)
ZA (1) ZA835201B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
CN101863907B (zh) * 2010-07-07 2012-05-23 福建省福抗药业股份有限公司 一种头孢哌酮钠的结晶方法
WO2014012849A1 (en) * 2012-07-17 2014-01-23 Dsm Sinochem Pharmaceuticals Netherlands B.V. A new crystal form of cefoperazone sodium
CN104327099A (zh) * 2014-09-29 2015-02-04 联合康兴（北京）医药科技有限公司 头孢哌酮钠化合物实体及组合物和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087424A (en) * 1974-05-09 1978-05-02 Toyama Chemical Co., Ltd. Novel penicillins and cephalosporins and process for producing the same
GB1508071A (en) * 1976-01-19 1978-04-19 Toyama Chemical Co Ltd Cephalosporins and process for producing the same
DE2600880C2 (de) * 1976-01-12 1984-09-13 Toyama Chemical Co. Ltd., Tokio / Tokyo Cephalosporinverbindungen
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration

Also Published As

Publication number Publication date
IE831666L (en) 1984-01-19
NO832598L (no) 1984-01-20
EP0101170B1 (en) 1986-01-15
PH19441A (en) 1986-04-18
GR79593B (sv) 1984-10-31
DK152051B (da) 1988-01-25
IE55433B1 (en) 1990-09-12
DK152051C (da) 1988-08-29
HK99487A (en) 1987-12-31
EG16058A (en) 1987-10-30
SU1194281A3 (ru) 1985-11-23
YU44123B (en) 1990-02-28
PT77041B (en) 1986-04-09
JPH0157115B2 (sv) 1989-12-04
CS235331B2 (en) 1985-05-15
FI832605A (fi) 1984-01-20
CA1190219A (en) 1985-07-09
DK330083D0 (da) 1983-07-18
PL243006A1 (en) 1984-08-13
IL69261A (en) 1987-03-31
KR860001495B1 (ko) 1986-09-27
DD213219A5 (de) 1984-09-05
ES524220A0 (es) 1984-11-16
ES8501372A1 (es) 1984-11-16
PL145167B1 (en) 1988-08-31
FI75169B (fi) 1988-01-29
AU1692283A (en) 1984-01-26
FI75169C (sv) 1988-05-09
ZA835201B (en) 1985-02-27
EP0101170A1 (en) 1984-02-22
YU154083A (en) 1986-06-30
MY8700729A (en) 1987-12-31
NO161743B (no) 1989-06-12
GT198302734A (es) 1984-12-25
AU537776B2 (en) 1984-07-12
HU192961B (en) 1987-08-28
JPS5929692A (ja) 1984-02-16
SG69787G (en) 1988-02-19
PT77041A (en) 1983-08-01
DK330083A (da) 1984-01-20
DE3361849D1 (en) 1986-02-27
NZ204930A (en) 1985-12-13
FI832605A0 (fi) 1983-07-18
US4458070A (en) 1984-07-03
IL69261A0 (en) 1983-11-30
KR840005456A (ko) 1984-11-12

Similar Documents

Publication Publication Date Title
NO161495C (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenyl)acetamido))-gruppeholdige cefalosporansyrederivater.
NO885789D0 (no) Fremgangsmaate for aa retardere dannelse av hydratagglomerater.
ES524215A0 (es) Procedimiento para la preparacion de nuevos derivados de acido 2-aza-biciclo(2.2.2)octan-3-carboxilico
NO884329D0 (no) Fremgangsmaate for fremstilling av vannfritt, krystallinsk natriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
IE830607L (en) Imidazolylphenylpyridazinones
NO161743C (no) Fremgangsm. for fremst. av krystallinsk natriumsalt av 7-(d(-(-)-a-(4-etyl-2,3-diokso-1-piperazinkarboksamido)-a-(4-hydroksyfenyl)acetamido)-3-(((1-metyl-1h-tetrazol-5-yl)tio)metyl)-3-cefem-4-karboksylsyre (cefoperazon).
NO162470C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv ester av 7beta-(2-(2-amino-tiazol-4-yl)acetamido)-3-(((1-(2-dimetylamino-etyl)-1h-tetrazol-5-yl)tio)metyl)-cef-3-em-4-karboksylsyre.
ES522058A0 (es) Procedimiento de preparacion de derivados de acido carbacico.
SE460365B (sv) Foerfarande foer rening av saltsura vattenloesningar, som innehaaller jaern(ii)klorid fraan kiselsyra
DK382580A (da) Fremgangsmaade ved fremstilling af natriumsaltet af (6r,7r)-3-acetoxymetyyl-7-( (z(-2-(fur-2-yl)-2-metoxyimonoacetamido)-ceph-3-em-4-karboxylsyre
ES516013A0 (es) Procedimiento para la obtencion de compuestos de acido 7b-aminooxazolilacetilamino-3-cefem-4-carboxilico.
ES508833A0 (es) Procedimientos para preparar derivados de acido cefaloesporanico.
ES521230A0 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
IT8322323A0 (it) Procedimento per la preparazione di un acido amminolattoncarbossilico.
MX9203468A (es) Novedoso acido 7-[2-(2-aminotiazol-4-il)-2-hidroxiiminoacetamido]-3-vinil-3-cefem-4-c arboxilico (isomero sin) cristalino.
ES526152A0 (es) Procedimiento para la formacion de acido acetico.
ES520799A0 (es) Derivados de acido pentanodioico.
ES513539A0 (es) Procedimiento para preparar derivados del acido cefaloesporanico.
DK500083A (da) Fremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)hydantoin-forbindelser eller farmaceutisk acceptable salte deraf
FR2499565B1 (fr) Procede de preparation de solutions aqueuses de methioninate de sodium (c)
IT8222160A0 (it) Procedimento per la produzione di acido clavulanico.
ES513963A0 (es) Procedimiento para la obtencion de compuestos del acido 7b-aminotriazolilacetilamino-3-cefem-4-carboxilico.
DK426778A (da) Fremgans fremgangsmaade til fremstilling af 7-(d(-)-alfa-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-alfa(4-hydroxyphenyl)acetamido)-3-(5-(1-methyl-1,2,3,4-tetrazolyl)-thiomethyl)-delta3-cephemt -4-carboxylsyre eller farmaceutisk acceptable salte deraf sam
IT1252307B (it) Procedimento enzimatico per la produzione di acido 7b- (4carbossibutanamido) cefalosporanici.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JULY 2003